about
Viral infections: a role in the lung disease of cystic fibrosis?Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.Calprotectin as a marker of inflammation in cystic fibrosisNeutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosisHyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system.Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis.Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes.Gene therapy for the respiratory manifestations of cystic fibrosis.Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene.In vitro tumor necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis.Circulating immunoreactive interleukin-6 in cystic fibrosis.Nutrition Status Parameters and Hydration Status by Bioelectrical Impedance Vector Analysis Were Associated With Lung Function Impairment in Children and Adolescents With Cystic Fibrosis.
P2860
Q28319242-CF758F6C-EA16-4BE5-BC3D-5B4BE8685D42Q33180176-45AC52D1-4F5B-40E0-8505-592462F8AF1DQ34128914-0DC78975-9F38-437B-8648-D8AF730D52EFQ34798243-526EB3BC-8564-4A61-94FB-4BB6DC704424Q35601919-0E5F89E1-A0D9-4307-82C7-C88B7593ACABQ36250630-B5B0F606-83AD-4BFC-BC8D-A3A4BF726C11Q36287704-D6BF2EA0-136D-4FED-9406-12D884FE60BBQ36940906-43BA901A-AD09-4BDD-919C-5D1631DE6ACFQ37576093-258053D5-FF2E-4547-87EB-E871112E5BC2Q39512990-545B1762-DF19-467B-BE5E-38A8F9DA3F96Q39517996-0D224197-ED2C-4A36-907F-AC58931C9661Q39818806-C00A5911-EE2B-43A5-A6DB-2131815B69C1Q39829680-F20A0C4A-321B-4AAB-A1A5-72325A7F6CB9Q40398397-027D800F-1DC4-4B60-9A88-08D191D3F0E3Q41078980-C18A90EE-C3CE-4716-B65C-6A6C7C3241A0Q42459532-97CEB8DF-C438-41C2-B145-313371FD64E8Q47991244-C6363E62-14E4-4945-9FD3-A7BFC78C2C9DQ53795351-C70DBA97-FA1F-4EF0-80EE-11C5C9BCAD9A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cystic fibrosis. 2. Lung injury in cystic fibrosis.
@en
type
label
Cystic fibrosis. 2. Lung injury in cystic fibrosis.
@en
prefLabel
Cystic fibrosis. 2. Lung injury in cystic fibrosis.
@en
P2860
P356
P1433
P1476
Cystic fibrosis. 2. Lung injury in cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1136/THX.45.12.970
P407
P577
1990-12-01T00:00:00Z